Teleflex
TFX
#2943
Rank
HK$46.49 B
Marketcap
HK$1,097
Share price
1.64%
Change (1 day)
8.72%
Change (1 year)
Categories
Teleflex Incorporated, is an American company providing specialty medical devices for a range of procedures in critical care and surgery.

P/E ratio for Teleflex (TFX)

P/E ratio as of August 2026 (TTM): -6.14

According to Teleflex's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -6.13912. At the end of 2025 the company had a P/E ratio of -5.94.

P/E ratio history for Teleflex from 2001 to 2026

PE ratio at the end of each year

Year P/E ratio Change
2025-5.94-104.88%
2024122275.54%
202332.42.74%
202231.62.21%
202130.9-44.23%
202055.451.86%
201936.5-35.73%
201856.7-19.58%
201770.5151.97%
201628.032.69%
201521.1
201323.6

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
Johnson & Johnson
JNJ
30.4-594.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Abiomed
ABMD
64.8-1,155.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Becton Dickinson
BDX
57.5-1,036.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Boston Scientific
BSX
19.4-416.72%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
40.0-751.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Cooper Companies
COO
59.5-1,068.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Merit Medical
MMSI
38.4-726.11%๐Ÿ‡บ๐Ÿ‡ธ USA
AngioDynamics
ANGO
-18.2 196.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Integra LifeSciences
IART
-2.70-56.01%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.